We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
+30.91%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$1.29B
AUM Growth
+$94.4M
Cap. Flow
-$78.5M
Cap. Flow %
-6.1%
Top 10 Hldgs %
48.93%
Holding
207
New
56
Increased
31
Reduced
35
Closed
51

Top Buys

Rank Stock Value
1
IOVA icon
Iovance Biotherapeutics
IOVA
+$30.6M
2
QURE icon
uniQure
QURE
+$18.4M
3
NVRO
NEVRO CORP.
NVRO
+$16.5M
4
TVTX icon
Travere Therapeutics
TVTX
+$12.9M
5
ARAV
Aravive, Inc. Common Stock
ARAV
+$12M

Top Sells

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$34.8M
2
RCPT
RECEPTOS INC COM STK (DE)
RCPT
+$21.8M
3
ESPR
Esperion Therapeutics
ESPR
+$19.5M
4
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$19.3M
5
TARO
Taro Pharmaceutical Industries Ltd.
TARO
+$18.5M

Sector Composition

Rank Sector Weight
1 Healthcare 84.11%
2 Miscellaneous 14.93%
3 Consumer Staples 0.85%
4 Technology 0.05%
5 Financials 0.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGEN
101
Agenus
AGEN
$322M
$929K 0.07%
9,228
-11,290
-55% -$1.13M
INCY icon
102
Incyte
INCY
$24.7B
$917K 0.07%
+10,000
New +$827K
INFI
103
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$853K 0.07%
61,000
+45,677
+298% +$698K
ABMD
104
DELISTED
Abiomed Inc
ABMD
$716K 0.06%
+10,000
New +$543K
EOCN
105
Eocene Ltd. Ordinary Shares
EOCN
$3.88M
$706K 0.05%
52
– –
IMPR
106
DELISTED
IMPRIVATA, INC COM
IMPR
$700K 0.05%
+50,000
New +$689K
ASPX
107
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
$602K 0.05%
+6,000
New +$400K
AKAO
108
DELISTED
Achaogen Inc
AKAO
$586K 0.05%
60,000
– –
ILMN icon
109
Illumina
ILMN
$33.6B
$531K 0.04%
+2,939
New +$554K
EGRX
110
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$506K 0.04%
+12,088
New +$343K
APYX icon
111
Apyx Medical
APYX
$125M
$478K 0.04%
+200,000
New +$665K
THC icon
112
Tenet Healthcare
THC
$21B
$449K 0.03%
8,500
-67,413
-89% -$3.15M
MDT icon
113
Medtronic
MDT
$120B
$390K 0.03%
+5,000
New +$379K
MRGE
114
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
$368K 0.03%
82,427
– –
ARIA
115
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$346K 0.03%
+41,949
New +$310K
HPTX
116
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$317K 0.02%
+6,913
New +$207K
VTRS icon
117
Viatris
VTRS
$19.1B
$305K 0.02%
5,133
-71,077
-93% -$4.05M
LCI
118
DELISTED
Lannett Company, Inc.
LCI
$297K 0.02%
1,098
– –
CBM
119
DELISTED
Cambrex Corporation
CBM
$291K 0.02%
7,331
-4,157
-36% -$123K
AET
120
DELISTED
Aetna Inc
AET
$275K 0.02%
2,586
– –
UHS icon
121
Universal Health Services
UHS
$10.4B
$263K 0.02%
2,233
– –
CI icon
122
Cigna
CI
$76.3B
$255K 0.02%
1,970
-249
-11% -$28.9K
UTHR icon
123
United Therapeutics
UTHR
$21.5B
$255K 0.02%
+1,481
New +$226K
ITGR icon
124
Integer Holdings
ITGR
$4.29B
$254K 0.02%
+4,817
New +$229K
HNT
125
DELISTED
HEALTH NET INC
HNT
$249K 0.02%
4,109
-916
-18% -$51.6K
3 4
5
6 7

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q1 2015 Portfolio in Review

As of Q1 2015, Perceptive Advisors held 207 positions worth $1.29B, up 7.9% from $1.19B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Perceptive Advisors withdrew a net $78.5M in Q1 2015, closing 51 positions and reducing 35 holdings. Its most notable exit was PTC Therapeutics, an estimated $34.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 80% a quarter earlier, followed by Miscellaneous and Consumer Staples.

Against the trend, Perceptive Advisors opened a new position in Iovance Biotherapeutics worth $32.9M.

  • Perceptive Advisors's largest Q1 2015 buy was Iovance Biotherapeutics: 2,714,549 shares worth $32.9M.
  • Perceptive Advisors added most to uniQure in Q1 2015, an estimated $18.4M increase.
  • Perceptive Advisors's biggest Q1 2015 reduction was RECEPTOS INC COM STK (DE), cutting an estimated $21.8M.
  • Perceptive Advisors fully exited PTC Therapeutics in Q1 2015, selling an estimated $34.8M.
  • Perceptive Advisors's ten largest holdings make up 49% of its $1.29B portfolio in Q1 2015.
  • Perceptive Advisors opened 56 new positions and closed 51 in Q1 2015.
  • Perceptive Advisors's portfolio value rose 7.9% quarter-over-quarter to $1.29B.

Based on Perceptive Advisors's 13F filing for Q1 2015, filed 15 May 2015.